Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NSTG

NSTG - NanoString Technologies Inc Stock Price, Fair Value and News

$0.11 
Market Closed

NSTG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NSTG Price Action

NSTG RSI Chart

NSTG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NSTG Valuation

NSTG Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NSTG Fundamentals

NSTG Revenue

NSTG Earnings

NSTG Profitability

NSTG Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023132.0M143.9M162.5M0
2022144.5M142.9M135.3M127.3M
2021122.3M133.6M138.9M145.1M
2020124.5M116.7M118.0M117.3M
2019111.3M116.7M118.7M125.6M
2018119.9M110.3M111.9M106.7M
201789.9M101.8M104.9M114.9M
201665.8M75.3M83.6M86.5M
201550.4M52.6M56.0M62.7M
201434.5M38.1M42.1M47.6M
201324.1M25.4M27.8M31.4M
201219.1M20.4M21.7M23.0M
201100017.8M
201000011.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About NanoString Technologies Inc

NSTG
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
 CEO
 WEBSITEnanostring.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES703